Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma. The gene discussed is PDCD1; the disease is intrahepatic cholangiocarcinoma.